4.8 Article

Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

A pH-/Enzyme-Responsive Nanoparticle Selectively Targets Endosomal Toll-like Receptors to Potentiate Robust Cancer Vaccination

Heming Xia et al.

Summary: This study reports a pH-/enzyme-responsive TLR7/8 agonist-conjugated nanovaccine (TNV) that intelligently responds to the endosomal environment and releases the TLR7/8 agonist precisely at the receptor site, resulting in effective immune activation.

NANO LETTERS (2022)

Article Multidisciplinary Sciences

pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages

Leonard Kaps et al.

Summary: In this study, liver fibrosis progression was prevented by repolarizing M2-type macrophages towards a non-fibrotic phenotype using a pH-degradable nanogel carrier system. The nanogels efficiently delivered the drug alendronate to nonparenchymal cells of fibrotic livers, reprogramming profibrotic M2 into antifibrotic M1 macrophages and preventing liver fibrosis progression. This approach has potential implications for the treatment of diseases driven by M2-type macrophages, including cancer.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Multidisciplinary Sciences

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts

Xin Li et al.

Summary: The study demonstrates that co-delivery of indocyanine green and calcipotriol using tumor cell-derived microparticles can enhance the efficacy of photothermal therapy by remodeling the tumor extracellular matrix and improving anti-tumor immune responses.

NATURE COMMUNICATIONS (2022)

Article Engineering, Biomedical

In Situ Tumor Vaccination with Calcium-Linked Degradable Coacervate Nanocomplex Co-Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti-Tumor Immune Responses

Yutong Liu et al.

Summary: This study reports a novel nanocomplex that can induce tumor antigen production, promote maturation of dendritic cells, and expansion of T cells through intratumoral injection and laser irradiation, showing potential for tumor suppression and therapeutic application in pre-operative and post-operative settings.

ADVANCED HEALTHCARE MATERIALS (2022)

Article Engineering, Biomedical

An Intelligent Nanovehicle Armed with Multifunctional Navigation for Precise Delivery of Toll-Like Receptor 7/8 Agonist and Immunogenic Cell Death Amplifiers to Eliminate Solid Tumors and Trigger Durable Antitumor Immunity

Yanyun Hao et al.

Summary: Intelligent nanovehicles accurately deliver drugs to tumor cells and dendritic cells, reducing tumor burden through immunogenic cell death and generating long-term immune protection.

ADVANCED HEALTHCARE MATERIALS (2022)

Article Chemistry, Multidisciplinary

Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast Cancer

Zitong Zhao et al.

Summary: In this study, walking dead TNBC cells were developed by conjugating anti-PD-1 and doxorubicin-loaded liposomes onto cell corpses for temporal chemo-immunotherapy against lung metastasis. The walking dead TNBC cells improved drug accumulation and local retention in the lungs, reprogrammed the lung microenvironment, and prolonged overall survival in mice with lung metastasis.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier-Free Nanoassembly of Fluorinated Prodrug and siRNA

Pengkai Wu et al.

Summary: A carrier-free nanoparticle is developed to simultaneously deliver chemotherapeutic drug, cytolytic peptide, and anti-TOX small interfering RNA. This nanoparticle can regulate T cell exhaustion and infiltration, and stimulate a robust immune response.

ADVANCED MATERIALS (2022)

Review Chemistry, Multidisciplinary

Extracellular-Vesicle-Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer-Immunity Cycle

Tuying Yong et al.

Summary: Immunotherapy against tumors has made progress but remains limited. Extracellular vesicle-based drug delivery systems can enhance immune responses by activating multiple steps of the cancer-immunity cycle.

ADVANCED MATERIALS (2022)

Article Biotechnology & Applied Microbiology

Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy

Xiaoyan Ge et al.

Summary: In this study, a pH/GSH-responsive triblock polymer-drug conjugate was developed to reduce immunosuppression and enhance the infiltration of CTLs by codelivering CPT and IMDQ in a controllable manner, providing a promising platform for synergistic tumor chemoimmunotherapy.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Article Chemistry, Multidisciplinary

Direct Presentation of Tumor-Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell-Mimicking Nanovaccines

Jie Zhang et al.

Summary: This study developed a personalized DC-mimicking nanovaccine for stimulating TAAs-specific T cell populations. By inducing BMDCs maturation and delivering TAAs through nanostructures, the nanoDCs efficiently generated potent antigen-specific T cell responses, leading to inhibition of tumor growth and metastases formation.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Tumor Selective Metabolic Reprogramming as a Prospective PD-L1 Depression Strategy to Reactivate Immunotherapy

Yu Liu et al.

Summary: In this study, a new PD-L1 regulation strategy was developed by selectively down-regulating PD-L1 expression in tumors using mitochondria-targeted IR-LND@Alb nanoparticles. The anti-tumor efficacy of this strategy was found to be superior to conventional anti-PD-L1 monoclonal antibodies. Interestingly, IR-LND also showed potential as a novel photodynamic therapy (PDT) drug with self-oxygen and self-PD-L1 regulation capability.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Engineering Poly(ethylene glycol) Nanoparticles for Accelerated Blood Clearance Inhibition and Targeted Drug Delivery

Yuan Tian et al.

Summary: Surface modification with poly(ethylene glycol) (PEGylation) improves the stability of nanoparticles (NPs) and reduces their uptake and clearance by the immune system. However, PEGylation can also trigger the accelerated blood clearance (ABC) phenomenon. This study presents a new type of stealth PEG NPs that can avoid the ABC effect and can be functionalized for targeted drug delivery to cancer cells.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Chemistry, Multidisciplinary

Controlling Disassembly of Paramagnetic Prodrug and Photosensitizer Nanoassemblies for On-Demand Orthotopic Glioma Theranostics

Ruibing An et al.

Summary: This study presents a glioma targeting and redox activatable theranostic nanoprobe for on-demand synergistic chemotherapy/photodynamic therapy (Chemo-PDT) of orthotopic gliomas. The nanoprobe disassembles and releases small molecules upon reduction by endogenous glutathione, allowing for synergistic Chemo-PDT. Additionally, the nanoprobe is capable of noninvasive detection and monitoring of orthotopic brain tumor growth. This research highlights the potential of targeted and activatable nanoagents for combinational cancer theranostics.

ACS NANO (2022)

Article Chemistry, Multidisciplinary

Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administration

Yanyun Hao et al.

Summary: In this study, a polymeric nano-immunomodulator was developed to selectively activate the immune system in tumors, enhancing T lymphocyte infiltration without causing immune-related adverse effects. It shows promising potential for safe systemic targeting delivery.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Materials Science, Multidisciplinary

Transforming cold tumors into hot ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy

Yunfei Yi et al.

Summary: In this study, peptide-based siRNA nanomaterials were developed to enhance the efficacy of antitumor immunotherapy. These nanomaterials respond to the tumor microenvironment and enable precise drug delivery and release. Photodynamic therapy mediated by these nanomaterials can eliminate solid tumors and induce immunogenic cell death, generating systemic immune responses. Additionally, the normalization of tumor vasculature and the silencing of tumor cells' resistance to immune effector cells further strengthen the antitumor immunogenicity.

MATTER (2022)

Article Chemistry, Multidisciplinary

Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer

Fengqi Zhou et al.

Summary: The study introduces a sequential prodrug nanovesicle designed to enhance drug delivery to tumor tissues and reduce immunological resistance of tumor cells. The nanovesicles show promising results in inhibiting tumor growth and suppressing metastasis in mouse models, providing a new approach for chemoimmunotherapy of cancers by overcoming immune evasion through the IFN-gamma-BRD4-PD-L1 axis.

NANO TODAY (2021)

Article Chemistry, Multidisciplinary

Developing Acid-Responsive Glyco-Nanoplatform Based Vaccines for Enhanced Cytotoxic T-lymphocyte Responses Against Cancer and SARS-CoV-2

Yanan Gao et al.

Summary: Cytotoxic T-lymphocytes (CTLs) play a central role in protective immunity against malignancies and infectious diseases. This study developed partially oxidized acetalated dextran nanoparticles (Ox-AcDEX NPs) as a general vaccine delivery platform. By conjugating CTL peptide epitopes and immune-enhancing adjuvants, effective vaccines against cancer and viruses were successfully created, demonstrating the potential for immune protection.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Chemistry, Multidisciplinary

Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD-L1 Expression for Circumventing Immune Resistance of Cancer

Fengqi Zhou et al.

Summary: This research addresses the issue of immune evasion in T-cell-based cancer immunotherapy by developing a multifunctional prodrug nanovesicle. By enhancing tumor antigen presentation and the infiltration of T lymphocytes, the prodrug nanovesicles demonstrate efficacy in overcoming immune resistance and potentiate tumor immunotherapy.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer

Rundi Song et al.

Summary: Researchers have developed a immunotherapy method that enhances the immunogenicity of tumor cells by inducing ferroptosis, thereby improving the efficacy of cancer immunotherapy.

ADVANCED MATERIALS (2021)

Article Multidisciplinary Sciences

Switchable immune modulator for tumor-specific activation of anticancer immunity

Yu Zhao et al.

Summary: Sw-IM is a chemical approach to limit systemic toxicity of immune stimulatory antibodies and cytokines by selectively masking and activating them in response to tumor-specific stimuli, thus enhancing the safety and efficacy of antitumor immunotherapies.

SCIENCE ADVANCES (2021)

Article Materials Science, Biomaterials

Imidazoquinoline-Conjugated Degradable Coacervate Conjugate for Local Cancer Immunotherapy

Hui Li et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)

Article Chemistry, Multidisciplinary

Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug Vesicles

Bi Wang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Review Immunology

Enhancing cancer immunotherapy with nanomedicine

Darrell J. Irvine et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Chemistry, Physical

Biomaterial-assisted targeted modulation of immune cells in cancer treatment

Hua Wang et al.

NATURE MATERIALS (2018)

Article Chemistry, Multidisciplinary

Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses

Lutz Nuhn et al.

ADVANCED MATERIALS (2018)

Review Nanoscience & Nanotechnology

Bioresponsive materials

Yue Lu et al.

NATURE REVIEWS MATERIALS (2017)

Article Immunology

PD-L1 expression on tolerogenic APCs is controlled by STAT-3

Sabine J. Woelfle et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2011)